Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 10.99 % | 4.71 % |
|
5yr average Equity Multiplier
|
1.02 | 1.23 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.25 | 0.64 |
|
5yr Avg Net Profit Margin
|
0.0 | 77.44 % | 5.84 % |
|
Price to Book
|
10.25 | 1.5 | 1.21 |
|
P/E
|
0.0 | 36.63 | 23.55 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 63.13 Days | -11.59 Days |
|
Inventory Days
|
0.0 | 54.75 Days | 56.66 Days |
|
Days Receivable
|
0.0 | 11.98 Days | 42.5 Days |
|
Days Payable
|
0.0 | 169.78 Days | 89.1 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 820.35 | 11.55 |
|
5yr Avg ROCE
|
-8.65 % | 17.27 % | 6.71 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -130.11 % | 7.54 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.07 |
|
5yr CAGR Net Profit
|
-15.95 % | -26.08 % | 18.95 % |
|
5yr Average Return on Assets
|
-8.47 % | 8.75 % | 3.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.36 % | 59.53 % | 66.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 1.0 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|